Professional Documents
Culture Documents
Discusion Resul Seminario 2
Discusion Resul Seminario 2
Sodium azide and D-mannitol had previously been used in biological assays (Ding et al. 2004;
Obata et al. 2009). Ding and collaborators tested the methyl ester of hematoporphyrin in the
presence of these ROS inhibitors and found inhibition of the photodynamic reaction by both
species.
Thus, these authors concluded that the photodynamic reaction, promoted by this photosensitizer,
led to the formation of both singlet oxygen and hydroxyl radical, concluding that these species were
involved in the type II and type I reactions, respectively (Ding et al. 2004). Similarly to these studies
it was found that photocytotoxicity in the presence of sodium azide or D-mannitol is significantly
reduced, increasing cell viability. Thus, the importance of the singlet oxygen and the type II
photodynamic reaction in the treatment with the photosensitizers 11a and 12a were confirmed, and
that the ROS formed by the type I photodynamic reaction are also involved in this process. For
chlorin 11a, the use of D-mannitol showed no significant differences with respect to the controls
also subjected to the treatment. This is indicative that, probably, the concentration of inhibitor used
is not sufficient to suppress ROS that are produced.
Type II reaction determines the formation of mainly singlet oxygen that occurs by transferring
energy from the photosensitizer to the oxygen. In parallel, in some cases the transfer of an electron
from the photosensitizer to the oxygen may also occur, which determines the formation of
superoxide anion. Since the formation of this species, typically associated with type I reaction
(Agostinis et al. 2011; Juarranz et al. 2008; Plaetzer et al. 2009), also occurs through direct
interaction between the photosensitizer and oxygen, some authors to classify it as type II (Foote
1991).
Ali-Seyed et al. evaluated the production of peroxides after PDT with Photolon™ over time. These
researchers observed a gradual increase in the production of these ROS from the 30 minutes, with
maximum after one hour, followed by a decline until three hours after treatment (Ali-Seyed etal.
2011). Another study that corroborated the results obtained was the Zhao et al. study, who verified
that in photosensitized lung adenocarcinoma cells with Photofrin® the intrecellular concentration of
ROS was inversely proportional to the concentration of photosensitizer. The concentration of ROS
was maximal at the concentration of 2.5 μg/mL and minimal when the photosensitizer
concentration was increased to 10 μg/mL (Hongyou Zhao, Xing, and Chen 2011).
Several authors have referred to the cytoprotective mechanisms of tumour cells to avoid the
cytotoxic effects of PDT. One of the mechanisms associated with this response depends on the
antioxidant molecules present in cells, whose concentration varies greatly between the various types
of tumour cells, as is the case with some amino acids, glutathione (GSH), or vitamin E. Another
mechanism is associated with the expression of enzymes capable of eliminating ROS, such as
superoxide dismutase (Agostinis et al. 2011).
2.2.5.4. Reduced glutathione
Reduced glutathione is an antioxidant enzyme capable of eliminating free radicals and reducing
peroxides (Chiou et al. 2010). In response to the photodynamic treatment based on the
photosensitizer 11a and 12a a reduction of this antioxidant defence is verified 24 hours after the
treatment. In human melanoma cells, where the results are represented in Figure 2.19 for chlorin
11a, the reduction is significant in the photodynamic treatment with the concentrations of 50 nM to
0.84 ± 0.09 (p<0.001), 250 nM to 0.80 ± 0.10 (p<0.001), and 500 nM to 0.84 ± 0.08 (p<0.001).
The same behavior is verified with chlorin 12a, where the reduction of this enzyme is significant at
concentrations of 50 nM to 0.85 ± 0.09 (p<0.001), 250 nM to 0.87 ± 0.08 (p<0.001), and 500 nM,
to 0.90 ± 0.10 (p=0.024).
Changes in reduced glutathione activity were reported after PDT with several photosensitizers and
in various cell types (Hadjur et al. 1996; Mikešová et al. 2013; Zhang et al. 2008).
There are several cellular mechanisms capable of interacting with the oxidants to form less reactive
products. However, under conditions of high oxidative stress, such as those occurring during PDT,
these cytoprotective mechanisms are insufficient and significant damage occurs in the cellular
constituents (Szokalska et al. 2009). Taking into account the results obtained and despite changes in
the antioxidant defences of the cells, their cytoprotective effect does not appear to be sufficient to
significantly limit the effect of photodynamic therapy based on the photosensitizers 11a and 12a.
Throughout this dissertation the results obtained in the experimental work were presented and
discussed. However, there are important conclusions that need to be emphasized, as well as the
prospect of future work.
In this study, we proceeded with the synthesis of a set of platinum chlorins with different
substituent groups in their tetrapyrrolic macrocycle (Ar = Ph, 4-ClC6H4 and 4-MeOC6H4)
corresponding to different polarities (esters, acids and alcohols). These chlorins were characterized
by 1H NMR, 13C NMR, mass spectrometry and UV-visible absorption spectroscopy.
Spectroscopically, it was concluded that the platinum complexes studied aggregated in aqueous
medium. Whereby a disaggregation study using different neutral surfactants (Glycerol, Pluronic
F127, Pluronic P123 and Tween 20) was performed. By studying the dark cytotoxicity of the two
surfactants that were found to disaggregate the metallochlorins, they proved to be cytotoxic per se,
reason why the other biological studies proceeded with the aggregated platinum complexes. In the
future it is intended to study the cytotoxicity of other surfactants, namely, non-ionic surfactants,
Triton X-100 and Brij-35.
From the cytotoxicity studies with the metallochlorins (in the aggregated form), in the human cells
of bladder carcinoma, esophageal carcinoma and melanocytic melanoma, it was concluded that
chlorins 11 (acid) and 12 (alcohol) have a photodynamic effect in vitro, unlike chlorins 10 (ester),
which were the most hydrophobic tested compounds. In conclusion, the polarity of these
derivatives affects their toxicity.
For chlorins 11 and 12, it was found that the inhibition of metabolic activity is proportional to the
increase of the concentration. Chlorins 11a and 12a were the photosensitizers that revealed a more
promising photodynamic effect against the three human tumour cell lines tested. The aromatic
group of these tetrapyrrolic macrocycle is a phenyl group (Ar = Ph). Thus, it can be concluded that
the nature of the aryl group of the macrocycle affects the photocytotoxicity of the derivatives
studied.
In this work, the dark cytotoxicity of photosensitizers 11a and 12a in normal human fibroblasts was
also considered. With this study it was determined that light activation is a fundamental
requirement for the cytotoxic activity of these photosensitizers and that their toxicity in normal
cells, if light activation does not occur, only occurs at concentrations well above the concentrations
tested (> 10 μM ).
For chlorins 11a and 12a, it was also proved that both apoptosis and necrosis are responses to
photodynamic treatment, however, apoptosis is associated with lower concentrations of
photosensitizers, whereas necrosis is associated with higher concentrations. Not only singlet
oxygen, formed from the type II photodynamic reaction, but also the ROS, formed through the
type I reaction, are involved in the lesion following PDT based on the photosensitizers 11a and 12a.
The activated cytoprotective mechanisms are not sufficient to inhibit the cellular damages
consequent to the photodynamic effect. Photodynamic therapy, due to its dependence on the
formation of transient ROS, is usually characterized as a phenomenon with appreciable short-term
consequences. For this reason, in the future, we also intend to evaluate the metabolic activity 2
hours after the photodynamic treatment.
The development of this experimental work allowed to gain further knowledge and promote
the general optimization of procedures. The aim was to develop photosensitizers with
therapeutic ability that, at the same time, can be used in molecular imaging. In the future, it is
planned to continue the development of new chlorin derivatives in order to achieve an
efficient photodynamic action, namely by conjugation of chlorins 11a and 12a with sugars.
With this structural change, both an increase in the solubility in aqueous medium and an
optimization of the selectivity of these photosensitizers regarding the tumour cells are
anticipated.